5-Aminolevulinic Acid (5-ALA) 24-Hour Urine Test in UAE | 750 AED | DHA-Approved Diagnostic Protocol

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited LC-MS/MS Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Correlation by DHA-Certified Consultant Medical Genetics.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Clinical Oversight: Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403

All results are interpreted within the context of clinical symptoms, family history, and biochemical correlation. A multidisciplinary approach with gastroenterology and nephrology is recommended for comprehensive management.

Test Overview & Methodology

The 5-aminolevulinic acid (5-ALA) 24-hour urine test quantifies ALA excretion to aid in diagnosing acute porphyrias, lead poisoning, and tyrosinemia. This biomarker is critical when patients present with unexplained abdominal pain, neurological symptoms, or photosensitivity. The test employs High-Resolution Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) with 99.9% diagnostic sensitivity, ensuring precise quantification even at low concentrations.

Feature	Our Test (DHA-Approved)	Closest Alternative
Precision & Methodology	High-Resolution LC-MS/MS with 99.9% Diagnostic Sensitivity	Conventional Column Chromatography with Spectrophotometry; variable interferences
Speed (TAT)	1 week	2–3 weeks
Accreditation	ISO 9001:2015 & DHA Compliance	Often non-accredited
Patient Support	24/7 WhatsApp +971 54 548 8731, post-test clinical guidance	Limited or no tele-support

Physician Insight & Safety Protocols

“In my clinical practice, elevated 5-aminolevulinic acid in a 24-hour urine collection serves as a cornerstone biomarker for diagnosing acute hepatic porphyrias, lead intoxication, and hereditary tyrosinemia type I. Interpretation requires integration with the patient’s porphyrin profile, genetic studies when indicated, and a thorough medication history. A negative result during an asymptomatic period does not rule out latent disease; serial monitoring may be warranted in at-risk individuals. I recommend close collaboration between the genetic counselor, gastroenterologist, and clinical biochemist to ensure accurate diagnosis and optimal patient outcomes.”

— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403

Medication Advisory – Do Not Alter Prescribed Therapy Without Medical Guidance

Sudden withdrawal or alteration of certain prescription medications may precipitate a severe acute porphyric crisis in genetically susceptible individuals. Never discontinue, reduce, or modify your medication regimen without direct consultation with your treating physician. Inform our clinical team of all drugs, including over-the-counter preparations and herbal supplements, before providing your urine sample.

Exclusion Criteria & Emergency Red Flags

Sample Rejection Criteria: Urine collected in uncovered vials, exposed to light, not refrigerated, or hemolyzed will be rejected. Use only the provided light-proof container and follow 24-hour collection instructions precisely.
Emergency Alert: If you experience sudden severe abdominal pain, confusion, seizures, muscle weakness, hallucinations, or difficulty breathing, seek immediate emergency medical care. These may indicate an acute porphyric crisis requiring urgent intervention.
Clinical Contraindications: Patients with known porphyria should avoid alcohol, smoking, and certain medications known to precipitate attacks. Discuss all risk factors with your genetic counselor before testing.

Patient FAQ & Clinical Guidance

1. Why is the 5-ALA urine test ordered?

The 5-ALA test diagnoses acute porphyria, lead poisoning, and tyrosinemia by detecting elevated aminolevulinic acid in a 24-hour urine collection. This biomarker is critical when patients present with unexplained abdominal pain, neurological symptoms (peripheral neuropathy, autonomic dysfunction), or photosensitivity. Early detection guides appropriate therapy and prevents progression to life-threatening complications.

2. How do I collect the 24-hour urine sample for 5-ALA?

Collect all urine produced over a full 24-hour period in the provided dark, refrigerated container to prevent light-mediated degradation of ALA. Discard the first morning void on day one, then collect every void including the first void on day two. Our phlebotomist supplies a pre-labeled light-proof container and provides detailed step-by-step instructions during home collection. Keep the container cool at 2–8°C throughout the collection period.

3. Do I need to stop medications before the 5-ALA test?

Never discontinue prescribed medications without explicit medical advice. Certain drugs can interfere with ALA quantification or trigger acute porphyric attacks in susceptible patients. Always consult your physician before the sample collection procedure to review your current therapy. Our clinical team can coordinate with your doctor to ensure safe medication management during the testing window.

UAE Regulatory & Data Privacy Adherence

Data Protection & Healthcare Compliance: This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. All patient data is encrypted and handled according to UAE healthcare privacy standards. Your personal health information is accessible only to authorized clinical personnel and is never shared without your explicit consent.

Accreditation: ISO 9001:2015 Certified. All laboratory processes adhere to international quality management standards.

Patient Support: For insurance verification, appointment scheduling, or clinical inquiries, contact us via WhatsApp at +971 54 548 8731 (24/7).

Clinical & Logistical Metadata

Test Name	5-Aminolevulinic Acid (5-ALA), 24-Hour Urine
Price (AED)	750 AED
Turnaround Time	1 week
Sample Type / Matrix	24-Hour Urine (light-protected, refrigerated)
Methodology Used	High-Resolution LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry)
ICD-10-CM Code	E80.2 (Other porphyria)
LOINC Code	14913-0 (5-Aminolevulinic acid [Mass/time] in 24 hour Urine)
DHA Facility License & Laboratory Address Invariants	License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians